FdaApplication
ANDA 213663
Identifiers
- fda_app_no: ANDA213663
Properties
| Property | Value |
|---|---|
| applicant_name | GRANULES INDIA LTD |
| application_type | ANDA |
| approval_date | 2020-09-24 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM | 25MG;220MG | TABLET;ORAL |
1 product